VINANTE, Fabrizio
 Distribuzione geografica
Continente #
NA - Nord America 6.468
EU - Europa 5.782
AS - Asia 2.072
SA - Sud America 19
AF - Africa 11
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 14.370
Nazione #
US - Stati Uniti d'America 6.434
GB - Regno Unito 2.443
CN - Cina 1.508
IT - Italia 543
SE - Svezia 524
FR - Francia 510
IE - Irlanda 447
DE - Germania 404
FI - Finlandia 369
SG - Singapore 325
RU - Federazione Russa 305
UA - Ucraina 151
JP - Giappone 70
TR - Turchia 39
VN - Vietnam 37
BE - Belgio 31
IR - Iran 29
CA - Canada 28
IN - India 23
CZ - Repubblica Ceca 11
KR - Corea 10
NL - Olanda 9
AU - Australia 8
HK - Hong Kong 8
PL - Polonia 6
SC - Seychelles 6
BR - Brasile 5
CL - Cile 5
EU - Europa 5
CH - Svizzera 4
SA - Arabia Saudita 4
AL - Albania 3
AR - Argentina 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PA - Panama 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AT - Austria 2
BG - Bulgaria 2
BO - Bolivia 2
CM - Camerun 2
CO - Colombia 2
CR - Costa Rica 2
ES - Italia 2
GE - Georgia 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
RO - Romania 2
AZ - Azerbaigian 1
BD - Bangladesh 1
IQ - Iraq 1
LU - Lussemburgo 1
MS - Montserrat 1
MY - Malesia 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 14.370
Città #
Southend 2.242
Jacksonville 1.362
Chandler 938
Woodbridge 715
Ashburn 607
Houston 545
Dublin 444
Ann Arbor 390
Singapore 229
Wilmington 200
Beijing 184
Lawrence 173
Princeton 173
Shenyang 162
Jinan 160
Nanjing 159
Verona 124
Sindelfingen 98
New York 87
Hebei 86
Zhengzhou 71
Tianjin 68
Changsha 65
Boardman 61
Taizhou 56
Nanchang 55
Haikou 54
Helsinki 53
Ningbo 52
Jiaxing 45
Hangzhou 41
Guangzhou 36
Milan 36
Taiyuan 33
Lancaster 32
Brussels 31
Falls Church 29
Fairfield 24
Norwalk 24
Seattle 24
San Francisco 23
Fuzhou 22
Redmond 22
Dong Ket 21
Lanzhou 19
Lonigo 19
Columbus 17
Dearborn 17
Düsseldorf 17
Kent 17
Bologna 16
Moscow 15
Rome 15
Washington 15
Auburn Hills 14
Los Angeles 13
Redwood City 13
Kochi 12
Philadelphia 12
Leawood 11
Kemerovo 10
Toronto 10
Dallas 9
Zanjan 9
Clearwater 8
Seoul 8
Shinchiba 8
Ardabil 7
Paris 7
Tsukuba 7
Châtenay-Malabry 6
London 6
Mahé 6
Ypsilanti 6
Cambridge 5
Edinburgh 5
Hong Kong 5
Melbourne 5
Montréal 5
Sacramento 5
San Diego 5
Tappahannock 5
Tokyo 5
Brno 4
Buffalo 4
Chicago 4
Cossato 4
Genoa 4
Groningen 4
Montreal 4
Orsogna 4
Qingdao 4
San Mateo 4
Trento 4
Verdun 4
York 4
Andover 3
Ankara 3
Bolzano 3
Des Moines 3
Totale 10.514
Nome #
Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation 354
Immunocitologia e immunoistologia delle cellule midollari normali e neoplastiche 321
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 148
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 135
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 129
Increased levels of soluble interleukin-2 receptor in the serum of patients with human immunodeficiency virus infection 126
Protein Tyrosine Phosphatase Receptor Type γ Is a Functional Tumor Suppressor Gene Specifically Downregulated in Chronic Myeloid Leukemia 124
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 124
Alpha (p55) and beta (p75) chains of the interleukin-2 receptor are expressed by AML blasts 123
I marcatori delle cellule linfoidi 123
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 122
L'alfa interferone nei pazienti con Hairy Cell Leukemia attiva il sistema NK, ma non induce un'attività citotossica specifica verso le cellule hairy 118
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 118
High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia 117
a (p55) and b (p75) chains of interleukin-2 receptor are expressed by AML blasts 117
Down-regulation of protein tyrosine phosphatase gamma (PTPRG) in chronic myeloid leukemia (CML) 117
α-bisabolol is an effective proapoptotic agent against BCR-ABL+ cells in synergism with Imatinib and Nilotinib 117
Biological prognostic factors in indolent lymphoma 115
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 113
Monoterapia empirica con ceftazidime nelle infezioni di pazienti neutropenici affetti da emopatie maligne 110
Leucemie 110
Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myeloma. 110
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 109
Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis 109
A study of the crosstalk between CD30 and CXCR4 109
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 109
IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells 108
Highly concentrated urine-purified Tac peptide fails to inhibit IL-2-dependent cell proliferation in vitro 107
Espressione e ruolo funzionale di CD30/CD30L e Fas/FasL in cellule endoteliali umane 106
Immunophenotypic approach to the detection of minimal residual disease in acute leukemia 105
Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes 104
Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome 104
BONE MARROW-DERIVED STROMAL CELLS INHIBIT SPONTANEOUS APOPTOSIS IN NORMAL AND NEOPLASTIC THYMOCYTES 104
CXCL12 and [N33A]CXCL12 in 5637 and HeLa Cells: Regulating HER1 Phosphorylation via Calmodulin/Calcineurin 104
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 103
Soluble interleukin-2 receptor in the serum of patients with Hodgkin's Disease: A new biological marker of disease activity 103
Expression and role of CD30/CD30L and Fas/FasL in human endothelial cells 102
Pro-apoptotic activity of α-bisabolol in preclinical models of primary human acute leukemia cells 102
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 101
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 100
The Sesquiterpene Oil {alpha}-Bisabolol Induces Apoptosis of B-Chronic Lymphocytic Leukemia Primary Cells 100
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. 99
Immunohistochemical and flow cytometric analysis of the expression of cyclin-dependent kinase 6 (CDK6, PLSTIRE) in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia 98
Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders 97
Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis 96
Gram-negative septicemia in patients with hematologic malignancies 96
Immunohistochemical demonstration of follicular dendritic cells in bone marrow involvement of B-cell chronic lymphocytic leukemia. 95
Bone marrow-, but not thymus-, derived stromal cells inhibit spontaneous apoptosis and induce proliferation in blasts of T-lineage ALL 95
Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15-20% of cases 94
Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders 92
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 91
Assetto citochinico e pattern del CD30 durante la maturazione del sistema immunitario 91
Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease 91
Cellular antigens and soluble molecules and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 91
AML blasts express heparin-binding epidermal growth factor-like growth factor (HB-EGF)/diphtheria toxin receptor 91
Immunologic abnormalities in angioimmunoblastic lymphadenopathy 90
CD30 e assetto citochinico dei linfociti T, valutato mediante analisi citofluorimetrica, in un caso di sindrome da iper-IgE asintomatica 90
Origin of the soluble interleukin 2 receptor in the serum of patients with hairy cell leukemia 90
Studio immunologico delle popolazioni linfoidi normali nella leucemia acuta mieloide in remissione completa. Evidenze di un possibile controllo immunologico della ricaduta 90
Bone marrow-derived stromal cells inhibit spontaneous apoptosis and induce proliferation in blasts of T acute lymphoblastic leukaemia: the role of interleukin 7 90
Il recettore per l'interleuchina-2 sulle cellule normali e neoplastiche 89
Differential expression of cyclin-dependent kinase 6 (CDK6, PLSTIRE) in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia. 88
Sesquiterpene α-bisabolol, which binds to Bid in lipid rafts, induces apoptosis in BCR/ABL+ cell lines through membrane depolarization. 88
Immunologic evidence of a strong association between non-Hodgkin lymphoma and simian virus 40 87
Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanisms 86
ICAM-1 tissue overexpression associated with increased serum levels of its soluble form in Hodgkin's disease 86
The CD4 molecule belongs to the phenotypic repertoire of most cases of acute myeloid leukemia 85
Comparative analysis of normal versus CLL B-lymphocytes reveals patient-specific variability in signaling mechanisms controlling LFA-1 activation by chemokines 85
Correlation between clinical features and circulating levels of soluble intercellular adhesion molecule-1 in Hodgkin's disease 84
HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation 84
Morphological and Functional Changes in the Peritumoral Adipose Tissue of Colorectal Cancer Patients 84
High serum levels of soluble interleukin-2 receptors in sarcoidosis 83
L'immunofenotipo nelle leucemie 83
Granulocyte-macrophage colony-stimulating factor induces expression of heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor and sensitivity to diphtheria toxin in human neutrophils 83
Presence of interleukin-2 receptor gamma chain transcript in AML blasts [letter] 82
CD30 triggering by agonistic antibodies regulates CXCR4 expression and CXCL12 chemotactic activity in the cell line L540. 82
CD30+ L540 cells express CCR5 and CXCR4 molecules, CCR3 mRNA and release RANTES and MIP-1alfa 81
Progressive polarization towards a Th(c)1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration 81
Empiric therapy of infections in hematologic malignancies: a prospective randomized trial 81
Soluble interleukin-2 receptor in hairy cell leukemia: A reliable marker of disease 81
Functional analysis of cytotoxic cells in patients with acute nonlymphoblastic leukemia in complete remission 80
Thymic epithelial cell-derived interleukin-7 promotes survival of human T-cell acute lymphoblastic leukemia 80
CD30 antigen and cellular biology of Reed-Sternberg cells 79
Le molecole solubili in oncoematologia 79
Rearrangement for the T-cell receptor gene and co-expression of immature T-cell markers and natural killer cell phenotype, in a patient with acute lymphoblastic leukaemia 79
Mitochondrial-Mediated Apoptosis by the Sesquiterpene Oil {alpha}-Bisabolol and Its Synergism with Imatinib and Nilotinib In BCR-ABL+ Cells. 79
Serum levels of soluble CD30 in chronic hepatitis type B 79
CD30 antigen and cellular biology of Reed-Sternberg cells [letter; comment] 78
High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS 78
Soluble molecules in lymphoproliferative diseases 78
Interleukin 7 requirement for survival of T-cell acute lymphoblastic leukemia and human thymocytes on bone marrow stroma. 78
Bone marrow mesenchymal stem cells express HER-1 and are sensitive to the effect of HB-EGF 77
In reply to Schäfer et al: new evidence on the role of endothelin-1 axis as a potential therapeutic target in multiple myeloma 77
Role of CD30 molecule in HIV-1 infection 76
Correlation between soluble interleukin-2 receptor and neoplastic bulk in hairy cell leukemia 76
Serum levels of soluble interleukin-2 receptor in Hodgkin's disease: relationship with clinical stage, tumor burden and treatment outcome. A longitudinal study 76
Role for IFN-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. 76
Membrane and soluble antigens and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 76
The Plant-Derived Agent {alpha}-Bisabolol Induces Apoptosis of Leukemic Blasts Ex Vivo. 76
JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia 76
Totale 10.083
Categoria #
all - tutte 42.292
article - articoli 28.548
book - libri 0
conference - conferenze 12.063
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.681
Totale 84.584


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.535 0 0 17 165 115 286 154 184 89 193 86 246
2020/20211.716 132 262 80 174 177 219 15 162 144 16 250 85
2021/20221.641 125 522 13 92 109 48 37 77 51 80 170 317
2022/20232.836 229 247 254 539 243 716 14 165 311 27 58 33
2023/20241.573 66 113 162 152 173 209 105 292 10 26 159 106
2024/2025493 216 248 29 0 0 0 0 0 0 0 0 0
Totale 14.525